Read More Pharma Industry News Day One Biopharmaceuticals, Merck sign licensing deal for MEK Inhibitors Day One Biopharmaceuticals has signed a licensing agreement with Merck to develop and commercialize pimasertib and MSC2015103B, two… bySrinathFebruary 23, 2021
